NVIDIA Corporation (NVDA)
| Market Cap | 4.49T |
| Revenue (ttm) | 187.14B |
| Net Income (ttm) | 99.20B |
| Shares Out | 24.30B |
| EPS (ttm) | 4.04 |
| PE Ratio | 45.78 |
| Forward PE | 26.43 |
| Dividend | $0.04 (0.02%) |
| Ex-Dividend Date | Dec 4, 2025 |
| Volume | 137,659,568 |
| Open | 183.22 |
| Previous Close | 184.86 |
| Day's Range | 183.02 - 187.12 |
| 52-Week Range | 86.62 - 212.19 |
| Beta | 2.31 |
| Analysts | Strong Buy |
| Price Target | 253.26 (+36.94%) |
| Earnings Date | Feb 25, 2026 |
About NVDA
NVIDIA Corporation, a computing infrastructure company, provides graphics and compute and networking solutions in the United States, Singapore, Taiwan, China, Hong Kong, and internationally. The Compute & Networking segment includes its Data Centre accelerated computing platforms and artificial intelligence solutions and software; networking; automotive platforms and autonomous and electric vehicle solutions; Jetson for robotics and other embedded platforms; and DGX Cloud computing services. The Graphics segment offers GeForce GPUs for gaming a... [Read more]
Financial Performance
In 2024, NVIDIA's revenue was $130.50 billion, an increase of 114.20% compared to the previous year's $60.92 billion. Earnings were $72.88 billion, an increase of 144.89%.
Financial StatementsAnalyst Summary
According to 39 analysts, the average rating for NVDA stock is "Strong Buy." The 12-month stock price target is $253.26, which is an increase of 36.94% from the latest price.
News
Nvidia to Invest $1 Billion in AI Drug Lab With Eli Lilly
Nvidia plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., in an effort to speed up the use of AI in the pharmaceutical industry. Denny Fish, portfolio manager on the ...
Eli Lilly CFO on $1 billion Nvidia investment
NVIDIA plans to invest $1 billion over five years in a new laboratory with Eli Lilly and Company, aiming to speed up the use of artificial intelligence in the pharmaceutical industry. Heres what Eli L...
Nvidia stock continues to crawl but analysts see strong upside ahead
Nvidia stock traded largely flat on Monday, showing little reaction to news of a major new partnership with Eli Lilly, as investors remained focused on the chipmaker's prospects in China and the broad...
Multiply Labs to Bring “Physical AI” Robotics Technology to Advanced Biomanufacturing With NVIDIA
SAN FRANCISCO--(BUSINESS WIRE)-- #MultiplyLabs--Multiply Labs, a leader in robotic biomanufacturing, today announced a landmark milestone in its mission to scale production of cell and gene therapies;...
Nvidia Partners With Eli Lilly on AI Drug Laboratory
Nvidia plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence in the pharmaceutical industry. Jessica Nix has more o...
EndoQuest to Bring AI-Powered Vision and Precision to Endoluminal Robotic Surgery with NVIDIA IGX Thor
HOUSTON--(BUSINESS WIRE)--EndoQuest Robotics, Inc., a pioneering leader in endoluminal robotic surgical technology, today announced new initiatives as part of their collaboration with NVIDIA to integr...
Nvidia, Eli Lilly to spend $1 billion over five years on joint research lab
Nvidia and U.S. pharma giant Eli Lilly will spend $1 billion building a new joint research lab in the San Francisco Bay area over five years which will use Nvidia's newest generation Vera Rubin AI chi...
Owkin Advances Frontier Model Development for Biological Artificial Super Intelligence, Accelerated by NVIDIA
SAN FRANCISCO & PARIS--(BUSINESS WIRE)--Owkin, an AI company on a mission to solve the complexity of biology, today announced a collaboration with NVIDIA to enhance OwkinZero, Owkin's biological large...
NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI
Companies to Jointly Invest up to $1 Billion Over Five Years in Infrastructure and Research Companies to Jointly Invest up to $1 Billion Over Five Years in Infrastructure and Research
NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery
News Summary: Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges. NVIDIA collaborates with Thermo Fisher to build autonomous lab infrastructure for scalable scientific di...
NVDA, INTC and AMD Forecast – Microchips Slightly Negative Early on Monday
Microchip stocks pull back in premarket trading as traders try to digest the latest headlines in the DoJ investigation of Jerome Powell, and the job report last week.
Nvidia Stock Drifts. China AI Chips and 1 Other Thing Can Reignite It.
Nvidia stock is down 1.8% over the past month.
January Dogs Of The Dow: One Ideal 'Safer' Dividend Buy
Verizon stands out as the only Dow stock meeting the 'dogcatcher' ideal: annual dividends from $1K invested exceed its single share price. Analyst projections suggest the top ten Dow Dogs could delive...
NVIDIA Is The Wrong Way To Play AI In 2026
The run that AI poster child NVIDIA (NVDA) has been on these last few years is truly incredible. That's not news, of course.
NVIDIA Corporation (NVDA) Discusses Rubin and Blackwell Performance Advancements and TPU Comparisons Transcript
NVIDIA Corporation (NVDA) Discusses Rubin and Blackwell Performance Advancements and TPU Comparisons Transcript
Jim Cramer says don't trade Apple and Nvidia as money rotates into overlooked stocks ahead of earnings season
Jim Cramer said uneventful labor data is allowing investors to focus on a broad rally spreading into overlooked parts of the market. Cramer said Apple and Nvidia are being sold to fund new opportuniti...
Nvidia stock remains rangebound: buy, sell or hold?
Nvidia stock has remained largely range-bound for several months despite strong demand for its artificial intelligence chips, and the company is now making a notable executive hire as it looks to rein...
This quietly dominant stock — plus Nvidia and Broadcom — are Mizuho's top chip picks
Lumentum's stock has quadrupled over the past year, but the optical component company plays into key AI themes that could fuel further gains.
This ‘Well Positioned' Stock Can Win Regardless as Broadcom and Nvidia Square Off
Broadcom and Nvidia can both win in the AI chip maker but there's one stock which could benefit from either coming out on top, according to Mizuho.
Nvidia Vs Broadcom: Which AI Stock To Bet On?
Broadcom experienced a decline of -17% over the past month. You might feel inclined to purchase more shares or perhaps consider decreasing your investment.
Humanoid robots take over CES in Las Vegas as tech industry touts future of AI
Across Las Vegas this week, tech companies used the CES trade show to reveal their visions of a future filled with physical artificial intelligence. Nvidia, AMD and Qualcomm made splashy robot-related...
Sarah Kunst of Cleo Capital eyes TSMC, global chips beyond Nvidia
Sarah Kunst, Managing Director at Cleo Capital says AI chip leaders won't ramp capex yet, pushing investors toward global names like Samsung and TSMC as retail money looks beyond crowded U.S. plays.
Focus: Nvidia and auto suppliers roll out partnerships to rekindle self-driving push
The short history of the self-driving car industry has been littered with expensive failures and endless delays, but tech suppliers, chipmakers including Nvidia and some automakers are betting on AI a...
Alibaba Steps Up AI Race With Potential Nvidia Mega Order
Alibaba Group Holding Ltd. (NYSE: BABA) stock rose Thursday after reports signaled expanded access to Nvidia Corp.'s (NASDAQ: NVDA) advanced artificial intelligence chips in China.